Legend Biotech (LEGN) Amortizatization of Intangibles (2020 - 2026)

Legend Biotech (LEGN) has 6 years of Amortizatization of Intangibles data on file, last reported at $100000.0 in Q2 2025.

• Quarterly Amortizatization of Intangibles fell 72.68% year-over-year to $100000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $908000.0 (down 59.32% YoY) and the FY2024 annual result came in at $1.9 million, changed 0.36% from the prior year.
• Amortizatization of Intangibles slipped to $100000.0 in Q2 2025, from $128000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $885000.0 in Q1 2024 to a low of $100000.0 in Q2 2025.
• A 5-year average of $441000.0 and a median of $392500.0 in 2021 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2021 — Amortizatization of Intangibles soared 1451.85% — and 2025, when it sank 85.54%.
• Tracing LEGN's Amortizatization of Intangibles over 5 years: stood at $419000.0 in 2021, then soared by 104.06% to $855000.0 in 2022, then plunged by 43.63% to $482000.0 in 2023, then slipped by 24.07% to $366000.0 in 2024, then tumbled by 72.68% to $100000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at $100000.0 (Q2 2025), $128000.0 (Q1 2025), and $366000.0 (Q4 2024), per Business Quant data.